In CRC, RAS association domain family 6 (RASSF6) is evidenced to be inhibited by miR-496, resulting in the Wnt/β -catenin signaling activation along with enhanced migration and EMT of CRC [151]. This evidence concerns the gene RASSF6 and colorectal carcinoma.